BIIB-028

Overview

BIIB-028 is an orally active inhibitor for heat shock protein 90 ( Hsp90 ) . BIIB-028 targets the ATP-binding site of Hsp90 , disrupts the function of Hsp90 , leads to the degradation of client proteins, that are crucial for cancer cell survival and proliferation.

Application

Products | Products > Signaling Pathways > Cell Cycle/DNA Damage | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > HSP

Product Information

• Catalog No.: HY-12933
• CAS No.: 911398-13-5
• Molecular Formula: C19H21ClN5O5P
• Molecular Weight: 465.83
• Purity: 99.98%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source